The medical-scientific team

Director of the CNRS - Inserm - CEA - NeuroSpin developmental neuroimaging laboratory, Ghislaine Dehaene-Lambertz is a pediatrician and CNRS research director in cognitive sciences, specializing in neuroimaging. She heads the developmental neuroimaging team at NeuroSpin, the CEA's brain imaging center in Saclay. A member of the Conseil Scientifique de l'Education Nationale (CSEN) and the US National Academy of Sciences, she participated in the commission on "The first 1,000 days of a child's life".

Head of the Child Psychiatry Department at Hôpital Robert-Debré AP-HP, Richard Delorme is Director of the Center of Excellence for Autism and Neurodevelopmental Disorders (INOVAND). He has extensive experience of child and adolescent psychiatric disorders. He is also a researcher at the Human Genetics and Cognitive Function Unit at the Institut Pasteur (Paris), and was instrumental in identifying the first genes involved in autism, leading to publications in prestigious international journals. He was a member of the commission on "The first 1,000 days of a child's life".

Professor at Université Paris Cité and Institut Pasteur, Thomas Bourgeron discovered the first mutations in the NLGN3, NLGN4X and SHANK3 genes, underlining the key role of the synapse in autism. He heads the Human Genetics and Cognitive Functions unit within the Neuroscience department of the Institut Pasteur, a research group that brings together psychiatrists, neuroscientists and geneticists to understand the interaction between genetic variations associated with autism. He holds a Chair of Excellence from the Bettencourt-Schueller Foundation. He is a member of the Académie des Sciences, the Comité consultatif national d'éthique (CCNE), the European Molecular Biology Organization (EMBO) and Academia.

Stéphane Auvin is a neuropediatrician and epileptologist. He is Professor of Pediatric Neurology at Université Paris Cité. He is Director of the Pediatric Neurology Department and Director of the Rare Epilepsy Center at Hôpital Robert-Debré AP-HP, and a member of the EpiCARE ERN network. His clinical and research activities focus on early pediatric epilepsy and epilepsy drug development. His translational research team works on early epilepsy and neurotransmission in the developing brain for new targeted treatments.